Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

miR-21 helps improve ovarian function recovery in treated mice.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Undiagnosed lupus can cause severe complications after epidural anesthesia, leading to muscle weakness and potentially death.

PRP injection for hair growth can cause reversible vision loss due to inflammatory optic neuropathy.

Ashwagandha is safe and effective for reducing perimenopausal symptoms.

Long-term healthy eating lowers testosterone and improves health in women with suspected PCOS.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

PCOS is linked to inflammation, and certain markers could help in its treatment.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Different types of PCOS need specific diagnosis methods and treatments.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Bicalutamide may help treat female pattern hair loss.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Microneedles are effective for painless drug delivery and promoting wound healing and tissue regeneration.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Diagnose PCOS in teens using irregular periods and high androgen levels, not ultrasound.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.